Latest stories on TEVA
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea® | TEVA Stock News
StockTitan67 · bullishproduct/pr
UroGen, Teva Settle Jelmyto Patent Dispute, License Generic
TipRanks58 · neutralgeneral
UroGen settles with Teva over Jelmyto patent dispute
Seeking Alpha53 · neutralgeneral
Teva to Present at the Goldman Sachs Global Healthcare Conference | TEVA Stock News
StockTitan50 · neutralgeneral
Teva to Present at the Goldman Sachs Global Healthcare Conference
Business Insider50 · neutralgeneral
Teva Shareholders Back Board, Executive Pay and Auditor
TipRanks53 · neutralgeneral
Teva's Growth Story Is No Longer Just Generic, It's Getting Branded
Seeking Alpha67 · bullishanalyst
Teva Pharmaceutical (TEVA) Reports Q1 Beat, Plans Amylyx Deal
Yahoo Finance68 · bullishearnings
Teva Stock Is at Its Highest Level in Nearly a Decade. Here's Why It Could Soar Even More.
Yahoo Top77 · bullishgeneral
Wall Street Thinks Teva Stock Still Has Room to Run After Soaring Over 100%. Here's Why Analysts Are Right.
Yahoo Top67 · bullishanalyst